William Blair Raises Earnings Estimates for Henry Schein

Henry Schein, Inc. (NASDAQ:HSIC - Free Report) - Equities research analysts at William Blair lifted their Q2 2025 earnings per share (EPS) estimates for Henry Schein in a report released on Monday, May 5th. William Blair analyst B. Vazquez now forecasts that the company will earn $1.19 per share for the quarter, up from their prior forecast of $1.17. The consensus estimate for Henry Schein's current full-year earnings is $4.74 per share. William Blair also issued estimates for Henry Schein's Q3 2025 earnings at $1.31 EPS, Q1 2026 earnings at $1.27 EPS, Q2 2026 earnings at $1.26 EPS and FY2026 earnings at $5.26 EPS.

A number of other analysts have also commented on HSIC. Wells Fargo & Company reduced their target price on Henry Schein from $80.00 to $75.00 and set an "equal weight" rating for the company in a report on Tuesday, May 6th. Jefferies Financial Group upped their target price on shares of Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a report on Thursday, January 23rd. UBS Group lowered their target price on shares of Henry Schein from $83.00 to $80.00 and set a "neutral" rating on the stock in a report on Wednesday, February 26th. StockNews.com cut shares of Henry Schein from a "buy" rating to a "hold" rating in a research report on Thursday, April 17th. Finally, Barrington Research dropped their price objective on shares of Henry Schein from $90.00 to $86.00 and set an "outperform" rating for the company in a research note on Tuesday, May 6th. Six analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $79.30.

Henry Schein Stock Down 0.3 %

NASDAQ:HSIC traded down $0.21 during trading hours on Thursday, reaching $68.68. 2,009,912 shares of the company traded hands, compared to its average volume of 1,636,207. Henry Schein has a 1 year low of $60.56 and a 1 year high of $82.49. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. The business's 50-day moving average price is $67.59 and its two-hundred day moving average price is $71.45. The stock has a market capitalization of $8.41 billion, a P/E ratio of 28.26, a P/E/G ratio of 2.13 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings data on Monday, May 5th. The company reported $1.15 earnings per share for the quarter, topping analysts' consensus estimates of $1.11 by $0.04. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The firm had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same period last year, the company earned $1.10 EPS. The business's quarterly revenue was down .1% compared to the same quarter last year.

Insider Activity at Henry Schein

In other Henry Schein news, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the sale, the chief executive officer now directly owns 62,688 shares of the company's stock, valued at $4,460,251.20. The trade was a 6.05 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Philip A. Laskawy sold 2,604 shares of the company's stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the transaction, the director now owns 24,805 shares of the company's stock, valued at approximately $1,762,147.20. The trade was a 9.50 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.08% of the company's stock.

Institutional Trading of Henry Schein

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Invesco Ltd. raised its stake in shares of Henry Schein by 0.4% during the 4th quarter. Invesco Ltd. now owns 4,963,409 shares of the company's stock worth $343,468,000 after buying an additional 17,552 shares in the last quarter. FMR LLC increased its holdings in shares of Henry Schein by 6.6% in the 4th quarter. FMR LLC now owns 3,498,033 shares of the company's stock valued at $242,064,000 after purchasing an additional 217,143 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Henry Schein by 0.5% during the fourth quarter. Geode Capital Management LLC now owns 3,169,033 shares of the company's stock worth $218,762,000 after buying an additional 14,876 shares in the last quarter. Palestra Capital Management LLC acquired a new position in Henry Schein during the fourth quarter worth about $182,988,000. Finally, Fiduciary Management Inc. WI increased its holdings in Henry Schein by 7.2% in the fourth quarter. Fiduciary Management Inc. WI now owns 2,488,335 shares of the company's stock valued at $172,193,000 after buying an additional 167,990 shares in the last quarter. 96.62% of the stock is owned by hedge funds and other institutional investors.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.